Bungco, Francisco M.
HRN: 24-58-63 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/20/2024
CEFTRIAXONE 1G (VIAL)
02/20/2024
02/28/2024
IV
2g
Q12h
Sepsis Prob Sec To Bacterial Meningitis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueUnspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes